3 completed, 2 recruiting, 1 active not recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Active not recruiting 1 |
Follow Primary Open Angle Glaucoma or Ocular Hypertension: new trials by email Literature Review of Primary Open Angle Glaucoma or Ocular Hypertension trials Research Report on Primary Open Angle Glaucoma or Ocular Hypertension
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Comparative Study of Intraocular Pressure Control Using Selective Laser Trabeculoplasty and Latanoprost as Initial Treatments for Primary Open Angle Glaucoma and Ocular Hypertension in Lagos State University Teaching Hospital Selective laser trabeculoplasty, Latanoprost (0.005%) - Primary Open Angle Glaucoma or Ocular Hypertension | Not applicable | Recruiting | Lagos State Health Service Commission | 138 | 2025-10-15 | 2025-12-30 |
| Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT Netarsudil ophthalmic solution 0.02%, Artificial tears - Primary Open Angle Glaucoma or Ocular Hypertension | Phase 4 | Active not recruiting | East Coast Institute for Research | 70 | 2025-06-27 | 2026-06-10 |
| Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension AR-13324 Ophthalmic Solution 0.02%, AR-13324 Ophthalmic Solution 0.04%, AR-13324 Ophthalmic Solution Placebo - Primary Open Angle Glaucoma or Ocular Hypertension | Phase 2 | Completed | Aerie Pharmaceuticals | 42 | 2017-11-15 | 2019-12-23 |
| Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Netarsudil Ophthalmic Solution 0.02%, Placebo Comparator - Primary Open Angle Glaucoma or Ocular Hypertension | Phase 2 | Completed | Aerie Pharmaceuticals | 20 | 2017-10-20 | 2019-08-06 |
| A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI Study DE-117 ophthalmic solution, Latanoprost ophthalmic solution 0.005% - Primary Open Angle Glaucoma or Ocular Hypertension | Phase 3 | Completed | Santen Pharmaceutical Co., Ltd. | 26 | 2016-07-02 | 2017-11-20 |
| A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients Direct Selective Laser Trabuloplasty - Primary Open Angle Glaucoma, Glaucoma | Recruiting | Brian Shafer | 60 | 2002-03-11 | 2025-07-22 |
Glaucoma, Open-Angle (6) · Ocular Hypertension (6) · Glaucoma (1)
Eye Diseases (6) · Glaucoma (5)
Latanoprost (1) · Lubricant Eye Drops (1)
Aerie Pharmaceuticals (2) · Brian Shafer (1) · East Coast Institute for Research (1) · Lagos State Health Service Commission (1) · Santen Pharmaceutical Co., Ltd. (1)
United States (4) · Japan (1) · Nigeria (1)
Nancy Ramirez-Davis (2) · Prof B. Adekoya, FWACS, MD (1)